SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD). Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologists and pneumologists selected based on their exp...

Full description

Saved in:
Bibliographic Details
Published in:Reumatología clinica (Barcelona) 2022-10, Vol.18 (8), p.443-452
Main Authors: Rodríguez Portal, José Antonio, Brito García, Noé, Díaz del Campo Fontecha, Petra, Valenzuela, Claudia, Ortiz, Ana María, Nieto, M. Asunción, Mena-Vázquez, Natalia, Cano-Jiménez, Esteban, Castellví, Iván, Aburto, Myriam, Bonilla, Gema, Hernández Hernández, María Vanesa, Francisco Hernández, Félix Manuel, Correyero Plaza, María, Castrejón, Isabel, Abad Hernández, Miguel Ángel, Narváez, Javier
Format: Article
Language:English
Subjects:
Artritis reumatoide
Diffuse interstitial lung disease
Enfermedad pulmonar intersticial difusa
Factores de riesgo
Incidence
Incidencia
Prevalence
Prevalencia
Prognosis
Pronóstico
Rheumatoid arthritis
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD). Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologists and pneumologists selected based on their experience in the field. Systematic reviews of the available evidence were conducted, and evidence was graded according to the Scottish Intercollegiate Guidelines Network (SIGN) criteria. Specific recommendations were made. Six PICO questions were selected, three of which analysed the incidence and prevalence of RA-ILD, associated risk factors, and predictors of progression and mortality. A total of 6 specific recommendations on these topics, structured by question, were formulated based on the evidence found and/or expert consensus. We present the first official SER-SEPAR document with specific recommendations for RA-ILD management developed to resolve some common clinical questions and facilitate decision-making for patients. Elaborar unas recomendaciones multidisciplinares para mejorar el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide (EPID-AR). Un panel de reumatólogos y neumólogos expertos identificó preguntas clínicas de investigación relevantes para el objetivo del documento. Se realizaron revisiones sistemáticas de la evidencia, que se graduó de acuerdo con los criterios del Scottish Intercollegiate Guidelines Network (SIGN). Tras ello, se formularon las recomendaciones. Se seleccionaron seis preguntas PICO, tres de las cuales específicamente evaluaron la incidencia y prevalencia de esta complicación, los factores de riesgo para su desarrollo, y los factores pronósticos de mortalidad y de progresión de la EPID-AR. Se formularon un total de 6 recomendaciones específicas sobre estos aspectos, estructuradas por pregunta, con base en la evidencia encontrada y/o consenso de expertos. Se presenta el primer documento oficial SER-SEPAR de recomendaciones específicas para el abordaje la EPID-AR, con el fin de ayudar en la toma de decisiones a los clínicos directamente implicados en su manejo y aproximar la práctica asistencial a la mejor evidencia posible.
ISSN:2173-5743
2173-5743
DOI:10.1016/j.reumae.2022.02.004